Evidence map›Paper›PMID 37298385›Full record

ReviewInternational journal of molecular sciences2023

Irina Medakina, Larisa Tsapkova, Vera Polyakova, Sergey Nikolaev, Tatyana Yanova, Natalia Dekhnich, Igor Khatkov, Dmitry Bordin, Natalia Bodunova

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. AdjuvantMicrobiology spectrum · 2026
    Trial
  2. Trial
  3. Association of Resistance-AssociatedAntibiotics (Basel, Switzerland) · 2026
    Article
  4. High Levels ofMicroorganisms · 2026
    Article
  5. The Effects ofJournal of clinical medicine · 2026
    Review
  6. Microbiota in cancer: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  7. Resistance to Clarithromycin and Fluoroquinolones inAntibiotics (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Overcoming antibiotic-resistantWorld journal of gastroenterology · 2025
    Review
  13. Hyperoside AlleviatesPolish journal of microbiology · 2025
    Article
  14. Tegoprazan dual and quadruple therapy forFrontiers in medicine · 2025
    Article
  15. Review
  16. Role of high-dose amoxicillin dual therapy forWorld journal of clinical cases · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Genetic Markers ofCurrent issues in molecular biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Irina MedakinaSBHI Moscow Clinical Scientific Center, 111123 Moscow, Russia.ORCID 0000-0001-5482-6498
Larisa TsapkovaSBHI Moscow Clinical Scientific Center, 111123 Moscow, Russia.ORCID 0000-0002-7206-8691
Vera PolyakovaSBHI Moscow Clinical Scientific Center, 111123 Moscow, Russia.ORCID 0000-0003-1782-2118
Sergey NikolaevSBHI Moscow Clinical Scientific Center, 111123 Moscow, Russia.ORCID 0000-0003-0673-3590
Tatyana YanovaSBHI Moscow Clinical Scientific Center, 111123 Moscow, Russia.ORCID 0000-0001-5146-6925
Natalia DekhnichFSBEI HE Smolensk State Medical University of the Ministry of Health of Russia, 214019 Smolensk, Russia.ORCID 0000-0002-6144-3919
Igor KhatkovSBHI Moscow Clinical Scientific Center, 111123 Moscow, Russia.ORCID 0000-0003-3107-3731
Dmitry BordinSBHI Moscow Clinical Scientific Center, 111123 Moscow, Russia.ORCID 0000-0003-2815-3992
Natalia BodunovaSBHI Moscow Clinical Scientific Center, 111123 Moscow, Russia.ORCID 0000-0002-3119-7673
Moscow Clinical Scientific Center · RUMoscow State University of Medicine and Dentistry · RUMinistry of Health of the Russian Federation · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Helicobacter InfectionsHelicobacter pyloriAmoxicillinAnti-Bacterial AgentsClarithromycinDrug Resistance, MicrobialHumansAmoxicillinAnti-Bacterial AgentsClarithromycinantibiotic resistancegeographical distribution of H. pylori antibiotic resistanceHelicobacter pylorimethods for determining H. pylori resistancemolecular genetic diagnosticsphenotypic methods for determining antibiotic resistance

Identifiers

PMID37298385
PMCPMC10253745
OpenAlexW4378715144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.